PNC Financial Services Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $280K | Buy |
5,755
+29
| +0.5% | +$1.41K | ﹤0.01% | 1978 |
|
|
2025
Q1 | $195K | Buy |
5,726
+1,380
| +32% | +$47K | ﹤0.01% | 2194 |
|
|
2024
Q4 | $171K | Buy |
4,346
+606
| +16% | +$23.9K | ﹤0.01% | 2327 |
|
|
2024
Q3 | $176K | Sell |
3,740
-604
| -14% | -$28.4K | ﹤0.01% | 2287 |
|
|
2024
Q2 | $235K | Buy |
4,344
+12
| +0.3% | +$648 | ﹤0.01% | 2029 |
|
|
2024
Q1 | $295K | Sell |
4,332
-1,057
| -20% | -$72K | ﹤0.01% | 1898 |
|
|
2023
Q4 | $337K | Sell |
5,389
-1,419
| -21% | -$88.8K | ﹤0.01% | 1773 |
|
|
2023
Q3 | $309K | Buy |
6,808
+4,183
| +159% | +$190K | ﹤0.01% | 1813 |
|
|
2023
Q2 | $147K | Buy |
2,625
+97
| +4% | +$5.45K | ﹤0.01% | 2417 |
|
|
2023
Q1 | $114K | Sell |
2,528
-300
| -11% | -$13.6K | ﹤0.01% | 2484 |
|
|
2022
Q4 | $115K | Sell |
2,828
-126
| -4% | -$5.12K | ﹤0.01% | 2485 |
|
|
2022
Q3 | $194K | Buy |
2,954
+126
| +4% | +$8.28K | ﹤0.01% | 2107 |
|
|
2022
Q2 | $172K | Sell |
2,828
-188
| -6% | -$11.4K | ﹤0.01% | 2242 |
|
|
2022
Q1 | $189K | Sell |
3,016
-9,661
| -76% | -$605K | ﹤0.01% | 2297 |
|
|
2021
Q4 | $960K | Sell |
12,677
-518
| -4% | -$39.2K | ﹤0.01% | 1294 |
|
|
2021
Q3 | $1.48M | Buy |
13,195
+219
| +2% | +$24.5K | ﹤0.01% | 1019 |
|
|
2021
Q2 | $2.1M | Sell |
12,976
-465
| -3% | -$75.3K | ﹤0.01% | 904 |
|
|
2021
Q1 | $1.64M | Buy |
13,441
+838
| +7% | +$102K | ﹤0.01% | 965 |
|
|
2020
Q4 | $1.93M | Buy |
12,603
+1,103
| +10% | +$169K | ﹤0.01% | 852 |
|
|
2020
Q3 | $961K | Buy |
11,500
+640
| +6% | +$53.5K | ﹤0.01% | 1057 |
|
|
2020
Q2 | $798K | Sell |
10,860
-10,100
| -48% | -$742K | ﹤0.01% | 1135 |
|
|
2020
Q1 | $888K | Buy |
20,960
+400
| +2% | +$16.9K | ﹤0.01% | 1020 |
|
|
2019
Q4 | $1.25M | Sell |
20,560
-286
| -1% | -$17.4K | ﹤0.01% | 999 |
|
|
2019
Q3 | $855K | Sell |
20,846
-800
| -4% | -$32.8K | ﹤0.01% | 1326 |
|
|
2019
Q2 | $1.02M | Hold |
21,646
| – | – | ﹤0.01% | 1273 |
|
|
2019
Q1 | $774K | Buy |
21,646
+60
| +0.3% | +$2.15K | ﹤0.01% | 1407 |
|
|
2018
Q4 | $616K | Buy |
21,586
+15,868
| +278% | +$453K | ﹤0.01% | 1455 |
|
|
2018
Q3 | $254K | Sell |
5,718
-4,176
| -42% | -$186K | ﹤0.01% | 2065 |
|
|
2018
Q2 | $581K | Buy |
+9,894
| New | +$581K | ﹤0.01% | 1562 |
|